Ryan Marotta, Assistant Editor

Drug prevents stroke and systemic blood clots in patients with atrial fibrillation.

The FDA today has granted accelerated approval to Boehringer Ingelheim's intravenous solution idarucizumab (Praxbind) for the rapid reversal of Pradaxa.

For a number of pharmacists, mass merchandiser pharmacies offer opportunities to provide patient care that may not be available to those in hospitals or smaller retail pharmacies.

The recent school shooting in Oregon has sparked a familiar conversation about mental illness in the United States.

The FDA has approved Alkermes' extended-release aripiprazole lauroxil injection (Aristada) for the treatment of schizophrenia in adults.

Learn about the new drugs and expanded indications approved by the FDA in September 2015.

Many community colleges have chosen to meet the increasing demand for highly trained pharmacy technicians by developing training courses.

Processing third-party claims and dealing with insurance companies can be frustrating even for the most experienced pharmacy technicians.

Marilyn Mootz, a pharmacy student at the University of Texas at Austin College of Pharmacy, firmly believes that pharmacists should influence positive change among their patients through exemplary care.

About 40,000 individuals commit suicide each year in the United States, but pharmacists have an important role to play in preventing these tragic deaths.

The FDA has approved the first and only 24-hour aspirin formulation.

Starting next month, military families and veterans with Tricare coverage will have to pay out-of-pocket for certain brand-name drugs if they chose to fill their prescriptions at retail pharmacies.

Pharmacy technicians should know the following new drugs and expanded indications approved by the FDA in August 2015.

Rico Powell, CPhT, shares his thoughts on the pharmacy technician's growing role in ensuring patient safety and improving health care outcomes.

As the technician's role on the pharmacy team continues to evolve, many current and future techs have turned to their local community colleges for training.

Recognized by her peers for her character and capabilities, Michele Pagel, PharmD, has been named Walmart's Market Health and Wellness Director of the Year.

The FDA has approved Orexo's sublingual buprenorphine/naloxone (Zubsolv) for the induction of buprenorphine maintenance therapy in patients with opioid dependence.

Senate draft of the 2016 NDAA includes copay hikes for brand-name and non-formulary medications.

Disagreements between federal lawmakers about Tricare co-payments have delayed the passage of the 2016 National Defense Authorization Act (NDAA).

Scott A. Meyers, RPh, MS, FASHP, shares his thoughts on pharmacy technicians and their growing role within the pharmacy team.

Many pharmacists dedicate themselves to improving the health of their patients and communities, but some answer an additional call: to provide their skills and knowledge in service to the military.

The FDA has approved anticonvulsant levetiracetam (Spritam) for the treatment of seizures in adults and children with epilepsy.

The California State Board of Pharmacy has suspended the license of a pharmacy technician who was revealed to have stolen the protected health information of approximately 100 patients.

Analysis provides solid support for the general safety of phase 1 trials.

Gavin Kivisto, PharmD, this year's winner of the Walmart Pharmacist Excellence in Patient Care Award, has dedicated himself to providing his patients with individualized care.

Pharmacists and technicians can prevent dispensing errors by using scan-verification and counting technology.

Even if they go undiagnosed or don't persist into adulthood, psychiatric problems in childhood can adversely affect adult outcomes.

The FDA has expanded the use of abobotulinumtoxinA injection (Dysport).

The FDA today approved Galderma Laboratories' antibiotic-free adapalene and benzoyl peroxide 0.3%/2.5% gel (Epiduo Forte Gel) for the once-daily treatment of acne vulgaris.

The FDA has approved Otsuka and Lundbeck's brexpiprazole (Rexulti) for major depressive disorder and schizophrenia.